NasdaqGS:GILDBiotechs
What Gilead Sciences (GILD)'s OncoNano Drug-Encapsulation Deal Means For Shareholders
OncoNano Medicine recently announced a research collaboration with Gilead Sciences to test its ON-BOARD encapsulation technology with a Gilead drug candidate, with OncoNano receiving an upfront payment plus potential preclinical, development, regulatory and commercial milestones, and royalties tied to future net sales.
The agreement also gives Gilead an option to nominate an additional target that could take total potential upfront and milestone payments to as much as US$300.00 billion,...